CREATE Study
C3G ICGN Real-World Evidence to Advance Transformative Care Study
Advancing Care Transforming Lives
500+
Target enrollment
~80
Participating sites
2025-2029
Study duration
About the Study
CREATE Study is a collaborative initiative to advance transformative care for patients with C3G and IC-MPGN.
​
The aim is to create a robust database, in collaboration with key academic and community medical centers, to advance knowledge and real-world evidence for these rare diseases.
​​
Join us to
Engage
in global scientific collaborations.
Become a member of GlomCon's Investigator Network.
Participate
in the forefront of clinical research.
Advance the care
for C3G and primary IC-MPGN patients.
A global effort to build a robust epidemiological registry​
.png)
Contribute to
Real-World Evidence
Help gather critical data and provide invaluable insights into C3G and IC-MPGN.
.png)
Expand Your Site's Role in Clinical Research
Participate in a prestigious multi-site study and support the professional development of early-career nephrologists.
.png)
Shape the
Future of Care
​Collaborate with leading nephrologists to shape patient care for C3G and IC-MPGN.
Access to Cutting-Edge Resources
Gain access to a secure, HIPAA-compliant, and FDA-approved platform for efficient data capture and management for this study, your own research projects, and beyond.
Funding Opportunities Available
Interested in participating in this initiative?
Click here or scan the QR code to submit your information and get in touch with us.
.png)